Walleye Capital LLC Cytokinetics Inc Transaction History

Walleye Capital LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $4.33 Million - $7.35 Million	67,999 Added 180.55%	105,662 $7.41 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $1.01 Million - $3.14 Million	37,663 New	37,663 $3.14 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $826,036 - $1.03 Million	25,323 New	25,323 $826,000
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $3.56 Million - $5.09 Million	99,560 Added 86.84%	214,204 $9.81 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.15 Million - $1.62 Million	29,784 Added 35.1%	114,644 $5.56 Million
Q2 2022 Aug 08, 2022	BUY	$33.93 - $48.92 $223,259 - $321,893	6,580 Added 8.41%	84,860 $3.33 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $2.33 Million - $3.6 Million	78,280 New	78,280 $2.88 Million
Q2 2020 Aug 14, 2020	SELL	$11.15 - $24.64 $351,392 - $776,529	-31,515 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $568 - $1,059	65 Added 0.21%	31,515 $372,000
Q4 2019 Feb 14, 2020	BUY	$7.95 - $11.84 $250,027 - $372,368	31,450 New	31,450 $333,000
Q3 2019 Nov 14, 2019	SELL	$10.82 - $14.25 $103,872 - $136,800	-9,600 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$7.95 - $11.25 $76,320 - $108,000	9,600 New	9,600 $108,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.9B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.